Eli Lilly to acquire cancer drug maker Kelonia - Search News

Eli Lilly to Buy Psychedelic Firm AtaiBeckley

· 18h · on MSN

Eli Lilly to buy AtaiBeckley for initial $2.8 billion

Eli Lilly has struck a deal to buy mental-health-focused AtaiBeckley for an initial $2.8 billion, continuing the drugmaker’s recent buying spree.

Continue reading

Axios Vitals on MSN · 14h

Eli Lilly agrees to $3.8B psychedelic buy

· 16h · on MSN

AtaiBeckley Stock Is Soaring 31% as Eli Lilly Agrees to Buy Psychedelic Drugmaker

Eli Lilly to Buy Psychedelic Firm AtaiBeckley for Initial $2.8 Billion

Eli Lilly LLY 0.35% has struck a deal to buy mental-health-focused AtaiBeckley ATAI -5.47% for an initial $2.8 billion, continuing the drugmaker’s recent buying spree.

Continue reading

Eli Lilly buys psychedelic biotech backed by Peter Thiel

Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley deal